Belite Bio Chief Scientific Officer Nathan L. Mata Sells 1,000 ADS Shares Under Rule 10b5-1 Plan

Nathan L. Mata, Chief Scientific Officer of Belite Bio, Inc. (BLTE), filed a Form 4 reporting the sale of 1,000 American Depositary Shares (ADS) on April 28, 2026. The transactions were executed in nine separate trades at prices ranging from $154.62 to $162.59 per share, with a total value of approximately $158,000. The sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025, which allows insiders to pre-arrange stock sales to avoid allegations of trading on non-public information. Following these transactions, Mata's ownership decreased from 7,666 ADS to 6,666 ADS, representing direct ownership. Each ADS represents one ordinary share of Belite Bio. The filing demonstrates compliance with insider trading regulations through the use of a pre-established trading plan.